| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the lives of patients following myocardial infarction by enabling faster recovery time and improved heart function. |
| Category: | Health & biotech |
| URL: | oriotx.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2023 |
| Address: | Route de l'Ile-au-Bois 3, Monthey, Valais 1870, CH |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/oriotx/ |
| Founders: |
No items found
|
| Awards won: | |
